OOIR: Observatory of International Research

Papers

(The H4-Index of Digestive and Liver Disease is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Comment on ``Clinical characteristics of immune checkpoint inhibitor-related pancreatic injury with pancreatitis in patients with advanced malignancies''	63
Beyond inflammation: Expanding the horizon on vascular risk assessment in inflammatory	63
NOSTRIN is an emerging positive regulator of decompensated cirrhotic patients with portal hypertension	60
Identification of causes and patterns of albumin structural damages in commercial formulations	55
Mapping the hepatic mtDNA genomic landscape in patients with MASLD: The Era of GPT-4 Artificial Intelligence	55
Relationship between recipient/donor features and liver stiffness measurement in the first year after liver transplantation	55
Assessment of sarcopenia with ultrasound-based measurements in patients with liver cirrhosis and correlation with clinical outcomes	50
Cardiometabolic risk factors and clinical course of liver cirrhosis	49
Full Title Page /Editorial Board	45
Predictive factors of health related quality of life in children and adolescents with celiac disease: An Italian multicenter study on behalf of the SIGENP	44
Establishing a nomogram for predicting necrotizing enterocolitis in premature infants: A retrospective multicenter cohort study	43
Comment on ``Dietary lipophilic index and odds of metabolic dysfunction-associated steatotic liver disease (MASLD): A population-based survey''	41
Renal cell carcinoma metastasis as an atypical cause of gastrointestinal bleeding	40
OC.04.7 EFFECT OF MTOR INHIBITION ON EXOSOMES ISOLATED FROMPC CELLS WITH DIFFERENT KRAS MUTATIONS	38
OC.09.5 ADVANCING IN ERCP: THE SLIM DUODENOSCOPE AS A CORNERSTONE FOR CHALLENGING ANATOMIES – INSIGHTS FROM AN ITALIAN CASE SERIES	37
OC.09.9 BALANCING RISKS AND BENEFITS: EVALUATING THE SAFETYAND EFFICACY OF CHOLANGIOPANCREATOSCOPY IN ELDERLY AND FRAIL POPULATIONS	36
OC.22.3 THREE-YEAR OUTCOMES OF ENDOSCOPIC SLEEVE GASTROPLASTY BY OBESITY CLASS	36
T.08.4 PRELIMINARY DATA FROM AN ONGOING MULTICENTER STUDY: EVALUATION OF THE DIAGNOSTIC ACCURACY OF CHATGPT-4 IN THE RECOGNITION AND CLASSIFICATION OF ESOPHAGEAL VARICES	35
OC.17.5 ENDOSCOPIC VACUUM THERAPY (EVT) FOR THE MANAGEMENT OF UPPER GASTROINTESTINAL TRACT LEAKS AND DEFECTS: A RETROSPECTIVE STUDY FROM ATERTIARY REFERRAL CENTER IN NEARLY 100 PATIENTS	35
T.03.5 EVALUATION OF RECTALWALL THICKNESS MEASUREMENT SENSITIVITY VIA TRANSABDOMINAL ULTRASOUND TO ASSESS MUCOSAL ACTIVITY IN ULCERATIVE COLITIS: COULD THIS BE A USEFUL NON-INVASIVE TOOL? A PRELIMINAR	33
T.10.4 APULIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (AN-IBD) SAFETY PROFILE: PILOT DATA	32
Liver transplantation following HCC rupture and long-term immunotherapy: a case report	31
OC.06.4 DEMOGRAPHIC DIFFERENCES IN LEFT-TO-RIGHT SHIFT OF COLON CANCER OVER 25 YEARS: RESULTS FROM ROBUST ANALYSIS OF CANCER REGISTRY DATA	31
Other than Insulin Antidiabetic Treatment Associates with Better Status of Frailty in Patients with Cirrhosis and Type 2 Diabetes on Waiting List for Liver Transplantation	31
How macronutrients and pancreatic enzyme supplements dose variability affect fat, protein and starch absorption in children with cystic fibrosis	31

Ileocaecal Crohn's disease. To resect or not to resect, is that the question?	31
OC.04.1 SURGERY IN HIGH-RISK PAEDIATRIC CROHN'S DISEASE TREATED WITH UP-FRONT ANTI-TNF AGENTS AND LONG-STANDING BIOLOGIC THERAPY	30
Gaining knowledge for the choice and use of systemic therapies in the treatment of hepatocellular carcinoma also requires real life and investigators conducted observational studies	30
Antitissue transglutaminase antibodies’ normalization after starting a gluten-free diet in a large population of celiac children-a real-life experience	30
Fully automated approach of machine learning combined with deep learning: How to predict the onset of major cardiovascular events in NAFLD patients	30